Three Virginia healthcare systems are joining forces as one of only eight groups in the United States to participate in groundbreaking research aimed at advancing the understanding and treatment of various forms of cancer. The Cancer Screening Research Network will include Sentara Health, the Sentara Health Research Center, and Eastern Virginia Medical School (EVMS) from Hampton Roads.
Cindy Allen, the administrative director for Sentara Health Research Center, expressed excitement about the potential findings of the research, stating, “Who knows what we will find? We may be leading to new guidelines, new standards of care.” This network represents the first large-scale initiative focused specifically on cancer screenings, with clinicians utilizing various screening methods like imaging, biomarkers, and new tests in their routine practices.
Dr. John Sayles, a colorectal surgeon with Sentara Medical Group, highlighted the goal of detecting cancer in its early stages by identifying DNA changes and mutations. The initial study, known as the Vanguard Study, will enroll up to 24,000 individuals aged 45 to 70 to inform a larger trial involving around 225,000 people. This trial will evaluate the benefits and risks of multi-cancer detection tests.
In Virginia, the three health organizations involved will investigate the effectiveness of liquid biopsy tests compared to standard cancer screening practices and assess the feasibility of incorporating them into primary care settings. By collecting data from diverse populations, both in Virginia and nationwide, researchers aim to enhance the accuracy of their findings.
“We implore people to consider participating in this study if invited,” urged Sayles, emphasizing the importance of diverse participation. No official launch date has been announced for the Vanguard study yet.
In addition to the research efforts of these Virginia health systems, it is worth noting the historical significance of collaborative initiatives like the Cancer Screening Research Network in driving advancements in cancer detection and treatment on a national scale. By uniting healthcare providers, researchers, and patients in the quest for improved cancer care, this initiative holds promise for shaping the future of oncology.
Read More Health News